CEO & Director
VistaGen Therapeutics
(NASDAQ: VTGN)
Shawn Singh has has nearly 30 years of experience working with private and public biotechnology, medical device, and pharmaceutical companies, a venture capital firm, and a profitable contract research and development organization (CRO), serving in numerous senior management roles.